VTAK logo

CATHETER PRECISION INC

VTAKNYSE AMERICAN
πŸ† #4156 by market capEarnings Nov 11US Equity
$0.29β–Ό $0.01 (βˆ’4.56%)
πŸŒ™ After hours$0.29β–Ό 1.02%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 4.6%
7dβ–² 12.5%
14dβ–² 4.7%
30dβ–Ό 55.6%
1yβ–Ό 91.1%
🏦Market Cap
$1M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+130.3%
High Growth
πŸ“ŠGross Margin
91.5%
High
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
1.0x
Cheap
Otter Score
53
Weak

Trading Snapshot

Day Range
$0.29 – $0.30
52-Week Range
$0.23 – $4.31
Volume
$3.62B
Avg Volume
$3.66B
Shares Outstanding
3.6M
Next Earnings
Oct 20, 2026

Fundamentals Snapshot

Annual Revenue
$819,000
Last Q Revenue
$432,000
P/E Ratio
β€”
P/S Ratio
1.0x
EPS (TTM)
$-13.16
Dividend Yield
β€”

Why Investors Own VTAK

  • βœ“High-growth profile β€” revenue up -9.6% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 26% gross margin and 30% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$819,000β–Ό βˆ’10.1% YoY
Gross Margin (TTM)
25.8%β–² +3.7% YoY
Operating Income (TTM)
$114,660β–Ό βˆ’10.1% YoY
Free Cash Flow (TTM)
$241,605β–Ό βˆ’10.1% YoY

About CATHETER PRECISION INC

Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
53/100

Analyst Price Target

β“˜
Average Target
$0.31
β–² +4.6% Upside
High Target$0.35
Low Target$0.28
Based on 38 analysts

Latest News & Updates